Riparian Pharmaceuticals inks license and research agreement with Pfizer for cardiovascular programs
Pfizer will make upfront and milestone payments, as well as pay royalties on sales of resulting therapeutics
Pfizer will make upfront and milestone payments, as well as pay royalties on sales of resulting therapeutics
CMOs showed an increasing reluctance to take on debt in 2022
To equip them with the latest knowledge and skills to handle patients coming to them in a better way
Planned investment of approximately USD 90 million to build a state-of-the-art Sandoz Biosimilar Technical Development Center in Ljubljana, Slovenia by 2026
Long COVID is a debilitating chronic condition that has affected over 100 million people globally
First of its kind screening for Glaucoma at grass root level over 10k screened already
Moist wound dressing for chronic wound treatment now available in Germany
Evonik specializes in mid- to large-scale, later clinical phase HPAPIs
The collaboration between CARER and Wholeleaf aims to offer an integrated approach to cancer patients, combining services and products to optimize their well-being
Chlorpromazine Hydrochloride Tablets USP had an estimated annual sale of USD 45 million in the U.S.
Subscribe To Our Newsletter & Stay Updated